MCK.F McKesson Corporation

Healthcare Health Care Providers & Services Frankfurt Exchange
966.20 EUR
Close of Nov 13, 2026
610.29 982.40
Market cap
EUR 112B
P/E
29.0x
P/B
4.97x
ROE
-
Dividend yield
0.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is MCK.F undervalued?

Graham number
Price966.20
Graham value381.93
Premium153.0%

MCK.F trades 153.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

McKesson Corporation fundamental analysis

No fundamental analysis for McKesson Corporation yet.

McKesson Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinic…

Full company profile